欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号
IT/H/0736/002
药品名称
CLINIMIX
活性成分
alanine 0.0 %
arginine 0.0 %
calcium chloride dihydrate 0.0 %
glucose monohydrate 0.0 %
glycine acetate 0.0 %
histidine 0.0 %
isoleucine 0.0 %
leucine 0.0 %
lysine hydrochloride 0.0 %
magnesium chloride hexahydrate 0.0 %
methionine 0.0 %
phenylalanine 0.0 %
potassium phosphate 0.0 %
serine 0.0 %
sodium chloride 0.0 %
sodium acetate 0.0 %
threonine 0.0 %
tryptophan 0.0 %
tyrosine 0.0 %
valine 0.0 %
剂型
Solution for infusion
上市许可持有人
Baxter S.p.A. Piazzale Dell'Industria 20 00144 - Rome Italy
参考成员国 - 产品名称
Italy (IT)
互认成员国 - 产品名称
Belgium (BE)
Netherlands (NL)
France (FR)
Poland (PL)
Cyprus (CY)
Czechia (CZ)
Sweden (SE)
United Kingdom (Northern Ireland) (XI)
Finland (FI)
Greece (GR)
许可日期
2008/04/05
最近更新日期
2024/06/21
药物ATC编码
B05BA10 combinations
申请类型
TypeLevel1:
[not specified]
TypeLevel2:
[not specified]
TypeLevel3:
[not specified]
TypeLevel4:
[not specified]
TypeLevel5:
[not specified]
附件文件下载
Final Labelling
|
common_outer_clean
Date of last change:2024/09/06
Final PL
|
common_pl_WS 58 Clinimix_
Date of last change:2024/09/06
Final SPC
|
common_spc WS 58 Clinimix
Date of last change:2024/09/06
市场状态
Positive
©2006-2024
Drugfuture
->
European Union HMA Authorisation of Medicines DataBase